Reva Medical closes a debt-and-options round worth $25 million to back the clinical program behind its Fantom bioabsorbable stent.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1vFE2F9
Cap comentari:
Publica un comentari a l'entrada